Literature DB >> 1169907

Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.

R Ferone, S R Bushby, J J Burchall, W D Moore, D Smith.   

Abstract

Rich media support the growth of bacteria in the presence of concentrations of sulfonamides and diaminopyrimidines that are highly inhibitory when the organisms are grown on minimal media. Many such rich media can be made more suitable for susceptibility testing by the incorporation of lysed horse blood. Harper and Cawston characterized the active substance, Harper-Cawston factor (HCF), and later studies indicated it to be a protein. It has now been identified as thymidine phosphorylase. The identification follows from the identical purification pattern of HCF and thymidine phosphorylase activities from horse blood to a high degree of purity. Blood of goats, sheep, oxen, geese, chickens, cows, dogs, rats, and humans had neither biological activity. The identification of HCF as thymidine phosphorylase is consistent with the earlier findings of Koch and Burchall (1971) that most of the interfering effects of rich media could be accounted for by their thymidine contents, and that thymidine is much more active in this respect than is thymine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1169907      PMCID: PMC429079          DOI: 10.1128/AAC.7.1.91

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  PYRIMIDINE NUCLEOSIDASES. THEIR CLASSIFICATION AND RELATIONSHIP TO URIC ACID RIBONUCLEOSIDE PHOSPHORYLASE.

Authors:  T A KRENITSKY; J W MELLORS; R K BARCLAY
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

3.  Computer programmes for processing enzyme kinetic data.

Authors:  W W CLELAND
Journal:  Nature       Date:  1963-05-04       Impact factor: 49.962

4.  The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue.

Authors:  M FRIEDKIN; D ROBERTS
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Horse erythrocyte factor enhancing sulphonamide activity. I. Partial purification and data on the mode of action.

Authors:  E T Gláz; T Machay
Journal:  Folia Microbiol (Praha)       Date:  1972       Impact factor: 2.099

7.  Inhibitor binding analysis of dihydrofolate reductases from various species.

Authors:  J J Burchall; G H Hitchings
Journal:  Mol Pharmacol       Date:  1965-09       Impact factor: 4.436

Review 8.  Pyrimidine metabolism in microorganisms.

Authors:  G A O'Donovan; J Neuhard
Journal:  Bacteriol Rev       Date:  1970-09

9.  Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.

Authors:  S R Bushby
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

10.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11
View more
  24 in total

1.  Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis.

Authors:  D S Black; A J Kelly; M J Mardis; H S Moyed
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

2.  Antimicrobial susceptibility testing of veterinary clinical isolates with the Sceptor System.

Authors:  J R Papp; C A Muckle
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

3.  Antimicrobial susceptibility of group B streptococci.

Authors:  K M Persson; A Forsgren
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

4.  Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?

Authors:  Asha C Bowen; Rachael A Lilliebridge; Steven Y C Tong; Robert W Baird; Peter Ward; Malcolm I McDonald; Bart J Currie; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

5.  Inactivation of diaminopyrimidines and sulfonamides in Barbour-Stoenner-Kelly medium for isolation of Borrelia burgdorferi.

Authors:  E C Reisinger; I Wendelin; R Gasser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

6.  Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants.

Authors:  D C Mills; T F Midura; S S Arnon
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

7.  Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.

Authors:  Helio S Sader; Thomas R Fritsche; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

8.  Susceptibility tests for sulfamethoxazole-trimethoprim by a broth microdilution procedure.

Authors:  J M Swenson; C Thornsberry
Journal:  Curr Microbiol       Date:  1978       Impact factor: 2.188

9.  Trimethoprim activity in media selective for Campylobacter jejuni.

Authors:  C A Bopp; J G Wells; T J Barrett
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

10.  Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci.

Authors:  P F Coll; V R Ausina; J V Vernis; B O Mirelis; G P Prats
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.